Related Experiment Video
Updated: Aug 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Human melanomas express functional P2 X(7) receptors
Nicholas White1, Peter E M Butler, Geoffrey Burnstock
1Autonomic Neuroscience Centre, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK.
Abstract:
Adenosine 5'-triphosphate is known to function as a potent extracellular messenger, producing its effects via a distinct family of cell surface receptors. Different receptor subtypes have been shown to modulate different cellular functions such as proliferation, differentiation and apoptosis. We have investigated the functional expression and apoptotic action of the P2 X (7) receptor in human malignant melanoma tissue and cells. Incubation of cells with the potent P2 X (7) receptor agonist 2'-3'-O-(4-benzoyl-benzoyl) adenosine 5'-triphosphate leads to a decrease in cell number, which is dose-dependent and reversible by the antagonist 1-N,O-bis-[5-isoquinoline-sulfonyl]-N-methyl-L-tyrosyl)-4-phenyl-piperazine. Synthesis of the P2 X(7) receptor by these cells has been established by reverse transcriptase-polymerase chain reaction, immunohistochemistry, immunocytochemistry and cellular accumulation of the fluorescent DNA-binding dye YO-PRO-1. The P2 X(7) receptors have been shown to mediate apoptotic actions of extracellular nucleotides and represent a novel target for melanoma therapy.
Insights
The P2X7 receptor, activated by extracellular adenosine triphosphate, triggers apoptosis in human malignant melanoma cells. This finding reveals the P2X7 receptor as a potential therapeutic target for melanoma treatment.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Adenosine 5'-triphosphate (ATP) acts as an extracellular messenger through specific cell surface receptors.
- Different receptor subtypes regulate critical cellular functions including proliferation, differentiation, and apoptosis.
Purpose of the Study:
- To investigate the functional expression and apoptotic effects of the P2X7 receptor in human malignant melanoma.
- To explore the P2X7 receptor as a potential therapeutic target for melanoma.
Main Methods:
- Utilized a potent P2X7 receptor agonist (2'-3'-O-(4-benzoyl-benzoyl) adenosine 5'-triphosphate) and antagonist (1-N,O-bis-[5-isoquinoline-sulfonyl]-N-methyl-L-tyrosyl)-4-phenyl-piperazine).
- Confirmed P2X7 receptor synthesis using reverse transcriptase-polymerase chain reaction, immunohistochemistry, and immunocytochemistry.
- Assessed apoptosis via cellular YO-PRO-1 dye uptake.
Main Results:
- P2X7 receptor activation by the agonist resulted in a dose-dependent and reversible decrease in melanoma cell number.
- Evidence confirmed the functional expression of P2X7 receptors in human melanoma cells.
- YO-PRO-1 uptake indicated P2X7 receptor-mediated cell death.
Conclusions:
- P2X7 receptors are functionally expressed in human malignant melanoma.
- Extracellular nucleotides acting via P2X7 receptors induce apoptosis in melanoma cells.
- The P2X7 receptor represents a novel therapeutic target for melanoma.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Abnormal Proliferation

